603301 振德醫療
按盤價 
21.540 +1.290 (+6.370%) | 2024/03 - 三個月 人民幣(K¥) | 與去年同期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 963,887 | -25.88% | 4,127,044 | 6,137,634 | 5,091,572 | 10,398,546 | |
| 減：營業總成本 | 870,158 | -23.22% | 3,740,278 | 5,246,611 | 4,356,103 | 6,786,088 | |
| 其中:營業成本 | 628,160 | -24.99% | 2,694,611 | 3,991,505 | 3,319,139 | 5,514,701 | |
| 財務費用 | (10,443) | 71.95% | (20,798) | 2,073 | 27,165 | 105,028 | |
| 資產減值損失 | (15,011) | -59,696.71% | (207,460) | (75,560) | (36,072) | (101,452) | |
| 公允價值變動收益 | (1,841) | -112.60% | (21,065) | (11,220) | (2,704) | (2,835) | |
| 投資收益 | 765 | -107.22% | 6,801 | (59,842) | 36,736 | 14,399 | |
| 其中：對聯營企業和合營企業的投資收益 | (28) | -93.68% | (632) | (2,196) | (302) | (271) | |
| 營業利潤 | 85,774 | -50.62% | 225,948 | 812,810 | 821,973 | 3,537,011 | |
| 利潤總額 | 85,036 | -50.43% | 218,892 | 801,716 | 819,949 | 3,533,087 | |
| 減：所得稅費用 | 9,806 | -58.40% | 5,492 | 99,959 | 99,002 | 561,187 | |
| 淨利潤 | 75,230 | -49.16% | 213,400 | 701,758 | 720,947 | 2,971,900 | |
| 減：非控股權益 | 1,832 | 20.27% | 15,001 | 21,879 | 125,085 | 422,447 | |
| 股東淨利潤 | 73,398 | -49.89% | 198,399 | 679,878 | 595,862 | 2,549,453 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.280 | -49.09% | 0.740 | 2.870 | 2.640 | 12.500 | |
| 每股派息 (元) * | -- | -- | 1.250 | 0.750 | 0.600 | 2.300 | |
| 每股淨資產 (元) * | 20.524 | -4.33% | 20.137 | 20.798 | 17.899 | 18.410 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | -- | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 05/07/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
